Saripada, Amina M.

HRN: 23-22-97  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/05/2026
02/07/2026
IV
1,120LD; Then 840mg
To Run Each Dose For 3 Hours
DM Foot Right; CAP MR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  PneumoniaBone & Joint    Compliance to guidelines: Compliant To Guidelines